September 21, 2018 — At the 2018 Transcatheter Cardiovascular Therapeutics (TCT) conference, Sept. 21-25 in San Diego, Siemens Healthineers will showcase new products that span the continuum of care in cardiology. Introducing solutions in both the laboratory and imaging spaces, Siemens Healthineers will debut a new ultrasound real-time intra-cardiac echo (ICE) catheter and High-Sensitivity Troponin I assays. The company is also a sponsor of the Interventional Imaging and Endovascular Pavilions at TCT, supplying hands-on workshops and simulations for continuing education.
With its new Acuson AcuNav Volume catheter, Siemens Healthineers is the first to market a real-time volume ICE catheter designed to meet the needs of structural heart interventionalists in the tradition of the acuson AcuNav family of catheters. By increasing to 90 x 50 degrees field of view, the new real-time volume ICE catheter provides complete visualization of heart valves, important for successful valve repair or replacement procedures. Along with the established capabilities and benefits of intracardiac echocardiography, such as reducing dose by requiring less fluoroscopy, real-time volume ICE offers clinicians a more flexible approach to sedation. Clinicians can use conscious sedation with the Acuson AcuNav Volume ICE catheter as opposed to general anesthesia, supporting safer and more efficient procedures, improved patient recovery and increased patient throughput. The Acuson AcuNav Volume ICE catheter is available exclusively on the Acuson SC2000 Prime ultrasound system, a complete structural heart disease solution delivering advanced visualization and artificial intelligence (AI)-powered quantification in 2-D and 3-D transthoracic echo ( TTE), transesophageal echo (TEE) and ICE.
For more information: www.usa.healthcare.siemens.com
April 30, 2024 
